Home > Pressrelease > Craniomaxillofacial Devices Market to exceed $3bn by 2030

Craniomaxillofacial Devices Market to exceed $3bn by 2030

  • Published Date: July 20, 2022

Craniomaxillofacial Devices Market size is set to surpass USD 3 billion by 2030, according to a new research report by Global Market Insights Inc.

The rise in the number of sports injuries leading to the increasing incidence of facial injuries and fractures, growing demand for minimally invasive reconstruction surgeries, surge in the prevalence of congenital facial deformities, and recent technological advancements in craniomaxillofacial devices is driving the market expansion.

Facial injuries & fractures caused due to sports activities comprise soft tissue injuries and fractures concerning nose and mandible along with dentoalveolar trauma. Players engaged in baseball, football, basketball, and softball often witness the highest incidence of facial fractures. Hence, these statistics are anticipated to encourage the people to undergo craniomaxillofacial surgery.

Growing incidence of congenital facial deformities will boost the craniomaxillofacial devices market size

Congenital facial deformities significantly drive the risk of infant mortality & childhood morbidity. This condition, as of 2021, affects approximately 6% of new-born babies across the globe, resulting in thousands of associated deaths. The congenital deformities encompass a broad spectrum of defects such as jaw deformities, the ossification of facial or cranial bones, malformed or missing teeth, and facial asymmetries. The increasing incidence is set to increase the application of craniomaxillofacial devices.

Strong product pipeline will spur the market revenue

Temporomandibular joint replacement system segment is anticipated to register 11.8% CAGR from 2022 to 2030. This is primarily attributed to the rising R&D activities along with upcoming products providing improved benefits to user. Total temporomandibular joint (TMJ) replacement system has been reported as an optimal option for the management of end-stage temporomandibular joint disease. These devices are developed to host a skull-based glenoid fossa component as well as a mandibular ramus or condyle.

Technological advancements and higher preference for customized devices will fuel the craniomaxillofacial devices market progression

Customized/patient-specific implants segment is estimated to witness 9.5% CAGR during the forecast period. This is pertaining to the technological advancements and higher preference for customized devices in craniomaxillofacial surgeries. Anatomically shaped patient-specific implants enable personalization of these devices aligned to the anatomy of the patient. Also, recent technological advancements have allowed the end-users to modify and customize the craniomaxillofacial devices as per their requirement.

Surged demand for craniomaxillofacial devices for external fixation will augment the market outlook

External fixators segment is projected to surpass USD 765 million by 2030. This is owing to the rise in the number of maxillofacial surgeries and surged demand for craniomaxillofacial devices for external fixation. External fixators are primarily intended for austere environments and multiple types of external fixators are used in emergency settings at hospitals for trauma care. The increase in demand and preference of the patients and healthcare professionals for minimally invasive surgical procedures while incorporating CMF implants for external fixation is likely to fuel the market revenue.

Multiple advantages provided by bioabsorbable materials will accelerate the craniomaxillofacial devices market trends

Bioabsorbable materials segment is poised to expand at 9.6% CAGR during the estimation timeframe. This is due to certain characteristics such as flexibility and resorbability offered by the material that readily adapts to anatomical shape as per the requirement. Bioabsorbable devices represent a viable alternative to conventional craniomaxillofacial devices and overcomes several drawbacks & toxicity complications. The implants are composed of polymers polyglycolide (PGA), polylactide (PLA), & their copolymers (PLGA and PLDLA) and represent immense potential in utility in craniomaxillofacial surgery. The application of bioabsorbable devices addresses several problems concerning conventional biostable devices.

Browse key industry insights spread across 584 pages with 1149 market data tables & 26 figures & charts from the report, “Craniomaxillofacial Devices Market Analysis By Product (MF Plate and Screw Fixation System, Cranial Flap Fixation System, CMF Distraction System, Temporomandibular Joint Replacement System, Thoracic Fixation System, Bone Graft Substitute System), Implant Type (Standard Implants, Customized/Patient-specific Implants), Location (Internal Fixators, External Fixators), Materials (Metals, Bioabsorbable Materials, Ceramics, Polymers), Application (Trauma Reconstruction Surgery {Cranial Surgery, Mid-face Surgery, Mandibular Surgery, Orbital Floor Reconstruction Surgery}, Orthognathic Surgery, Plastic Surgery), Resorbability (Resorbable Fixators, Non- Resorbable Fixators), Device Type (Reconstruction Surgery Devices, Trauma Surgery Devices), End-use (Hospitals, Ambulatory Surgery Centers), Industry Analysis Report, Regional Outlook, Application Development Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:


Growing number of traumatic events will spur the craniomaxillofacial devices market value

Trauma reconstruction surgery segment is slated to reach USD 1.1 billion by 2030. This is driven by the increase in the number of traumatic events and road accidents causing facial fractures and injuries. Such injuries lead to facial injuries requiring craniomaxillofacial surgeries. Moreover, growing treatment of orbital and mid-facial fractures, and peri-orbital soft tissue injuries is further set to boost the demand and adoption rate of craniomaxillofacial devices.

Accessibility, wide commercial availability, and compatibility with the facial tissues will stimulate the business growth

Non-resorbable fixators segment predicted to exceed USD 2 billion by 2030. This is owing to accessibility, wide commercial availability, and compatibility with the facial tissues & large usage of non-resorbable fixators in dentistry and neurosurgery. Hence, the afore-mentioned factors will drive the market value.

Increase in number of new-borns with congenital face deformities will the propel craniomaxillofacial devices market expansion

Reconstruction surgery devices segment is estimated to progress at 9.1% CAGR during the analysis period. This is due to the increase in number of new-borns with congenital face deformities such as cleft palate and cleft lip. Also, rise in number plastic surgeries across the globe is expected to further augment the industry scenario.

Growing preference and steady shift towards ambulatory surgical centers will foster the craniomaxillofacial devices market statistics

Ambulatory surgical centers segment is likely to witness 10.6% CAGR during the estimate period. The is due to several advantages offered to the patients including quality of care, low cost, and convenience in the ambulatory surgery centers. Also, majority of the surgical procedures conducted in the ambulatory surgical centers are less expensive and affordable as compared to the surgeries performed in hospitals.

Rising prevalence of trauma events leading to facial injuries in UK is estimated to accelerate the business demand

UK craniomaxillofacial devices market accounted for 12% revenue share in 2021 and is expected to register a significant CAGR through 2030. This is led by the rise in occurrence of traumatic events that fuel the incidence of facial injuries. Several research articles indicate that the incidence of facial fractures is surging and are majorly caused due to assault or road traffic collisions. Such injuries represent major precursors that promotes the application of craniomaxillofacial devices in surgeries. As a result, the rising number of traumatic events in UK is projected to amplify the business growth.

Prominent players are focusing on strategic initiatives and novel product launches to expand business operations

Some of the major players operating in the craniomaxillofacial devices industry are Johnson & Johnson, Stryker Corporation, Medtronic, Aesculap Implants Systems (B Braun Melsungen AG), and Zimmer Biomet. These players are involved in mergers & acquisitions, partnerships, and distribution agreements to gain competitive advantage over their competitors.

Authors: Sumant Ugalmugle, Rupali Swain

Explore More on Related Topics: